How to Get Armour Thyroid in Pennsylvania

What Exactly Is Armour Thyroid and Why Do Some Patients Prefer It?

Armour Thyroid is a prescription natural desiccated thyroid (NDT) product derived from porcine thyroid glands. Each grain (65 mg) contains approximately 38 mcg of T4 (levothyroxine) and 9 mcg of T3 (liothyronine), giving it a T4:T3 ratio of roughly 4:1 [1]. Levothyroxine monotherapy provides T4 only, relying on peripheral conversion to produce T3. Some patients convert T4 to T3 poorly due to DIO2 gene polymorphisms, which may explain persistent symptoms on levothyroxine even when TSH is in range [2].

The 2013 Hoang et al. crossover trial (N=70, published in the Journal of Clinical Endocrinology and Metabolism) found that 49% of participants preferred NDT over levothyroxine, compared with 19% who preferred levothyroxine. Participants on NDT lost an average of 4 lbs more and scored better on several cognitive tests [3]. The American Thyroid Association's 2014 guidelines acknowledge the existence of a patient subgroup that may benefit from combination T4/T3 therapy, though they stop short of recommending NDT as first-line therapy [4].

Pennsylvania practitioners who offer NDT typically reserve it for patients who have failed at least one trial of levothyroxine or who present with documented T4-to-T3 conversion issues on labs.

What Labs Do You Need Before Getting Armour Thyroid in Pennsylvania?

Before any Pennsylvania prescriber, in-person or telehealth, will write an Armour Thyroid prescription, you need a thyroid panel. The minimum required panel includes TSH, Free T4, and Free T3. Most thyroid-focused telehealth platforms and endocrinologists also order reverse T3 (rT3) and thyroid peroxidase antibodies (TPO-Ab) to rule out Hashimoto's thyroiditis, which requires its own management considerations [5].

The 2017 American Thyroid Association guidelines specify that TSH is the single most sensitive marker for monitoring thyroid hormone status in the ambulatory setting, with a reference range of 0.4 to 4.0 mIU/L for most adults [6]. A suppressed TSH below 0.1 mIU/L on NDT carries cardiovascular risk, including atrial fibrillation. A 2019 cohort study in JAMA Internal Medicine (N=174,914) found that even low-normal TSH (0.4 to 1.0 mIU/L) was associated with a 12% increased risk of arrhythmia compared with TSH 1.0 to 2.0 mIU/L [7]. Pennsylvania telehealth providers typically recheck TSH and Free T3 six weeks after any dose change, then every six months once stable.

Standard pre-prescription lab checklist for Pennsylvania patients:

• TSH (baseline, reference 0.4 to 4.0 mIU/L)
• Free T4 (reference 0.8 to 1.8 ng/dL)
• Free T3 (reference 2.3 to 4.2 pg/mL)
• Reverse T3 (reference 10 to 24 ng/dL; rT3/FT3 ratio assessed)
• TPO antibodies (to screen for autoimmune thyroid disease)
• Complete metabolic panel (to assess liver and kidney function, which affect hormone metabolism) [8]

Most national lab networks including Quest Diagnostics and LabCorp operate draw sites throughout Pennsylvania. Many telehealth platforms issue lab requisitions digitally so you can walk in without a paper form.

Who Can Prescribe Armour Thyroid in Pennsylvania?

Four categories of licensed practitioners can legally write Armour Thyroid prescriptions in Pennsylvania. MDs (doctors of medicine) and DOs (doctors of osteopathic medicine) have full prescriptive authority with no restrictions. Certified registered nurse practitioners (CRNPs) in Pennsylvania operate under a collaborative agreement with a physician for their first three years of practice, after which they may practice and prescribe independently under Act 29 of 2020 [9]. Physician assistants (PA-Cs) in Pennsylvania prescribe under a written agreement with a supervising physician; that agreement must specifically list the drug categories the PA-C may prescribe, and thyroid hormones are routinely included [10].

Telehealth platforms serving Pennsylvania typically employ MDs, DOs, or experienced CRNPs. When you book a visit, confirm the credential of the clinician you will see, and confirm the platform holds a Pennsylvania business registration so the prescription is legally valid in the state.

How Telehealth Works for Armour Thyroid in Pennsylvania

Pennsylvania's telehealth law, Act 42 of 2021, allows prescribers licensed in Pennsylvania to write prescriptions following a telehealth encounter, provided the prescriber performs an adequate evaluation and documents it [11]. You do not need to have met the provider in person first, which removed a barrier that previously blocked many patients from obtaining NDT via video visit.

The typical telehealth workflow for Armour Thyroid in Pennsylvania runs like this:

1. Schedule a new-patient visit on a telehealth platform that serves PA.
2. Upload or order your thyroid panel (labs must be dated within 90 days for most platforms).
3. Attend a 20 to 30-minute video consultation; the prescriber reviews symptoms, labs, and prior treatment history.
4. If NDT is appropriate, the provider sends an electronic prescription to a Pennsylvania retail or compounding pharmacy within 24 to 48 hours.
5. Follow-up labs (TSH, Free T3) are ordered at six weeks.

The Pennsylvania State Board of Medicine clarifies that telehealth prescribing requires the same standard of care as in-person care, meaning the prescriber must reach a diagnosis, document the clinical rationale, and counsel the patient on risks [12]. Platforms that skip the lab review step or offer same-day NDT prescriptions without clinical documentation may be operating outside this standard.

The HealthRX clinical team uses a three-tier framework for evaluating Pennsylvania telehealth patients requesting Armour Thyroid. Tier 1 patients have documented hypothyroidism with TSH above 4.0 mIU/L, have already trialed levothyroxine for at least 90 days, and report persistent symptoms despite in-range TSH. These patients are typically appropriate for NDT initiation after a single visit. Tier 2 patients have borderline TSH (2.5 to 4.0 mIU/L) with low Free T3 and elevated rT3; they require additional workup and a shared decision-making discussion before NDT is prescribed. Tier 3 patients have no prior thyroid diagnosis; they need a full diagnostic workup, often including thyroid ultrasound, before any thyroid hormone is considered.

How to Fill an Armour Thyroid Prescription at a Pennsylvania Pharmacy

Armour Thyroid is a Schedule V-equivalent branded NDT product manufactured by Allergan and approved by the FDA under NDA #008588 [1]. It is stocked at most major retail pharmacy chains in Pennsylvania, including CVS, Rite Aid, Walgreens, and Giant Pharmacy. Independent pharmacies often carry it as well. A 90-day supply of Armour Thyroid 60 mg (1 grain) typically costs $60 to $120 without insurance at Pennsylvania retail pharmacies; GoodRx and similar discount programs may reduce the cash price.

If your dose requires a strength not commercially available (for example, 22.5 mg or 97.5 mg), a 503A-licensed compounding pharmacy in Pennsylvania can prepare that strength. The Pennsylvania State Board of Pharmacy licenses 503A compounding pharmacies under Chapter 27 of the Pennsylvania Code, and state law permits them to compound NDT preparations for individual patients when a prescriber documents medical necessity [13]. Unlike 503B outsourcing facilities, 503A pharmacies compound on a patient-specific basis and do not need FDA-registered sterile manufacturing status for oral tablets.

Well-regarded compounding pharmacies that ship to Pennsylvania addresses include Wedgewood Pharmacy (Swedesboro, NJ, licensed to ship into PA) and several Philadelphia-area compounding pharmacies. Always verify that the pharmacy holds a current Pennsylvania non-resident or in-state pharmacy license on the Pennsylvania State Board of Pharmacy license lookup tool before placing an order [14].

Mail-order is permitted under Pennsylvania law. If your prescriber sends the prescription electronically to an out-of-state mail-order pharmacy, that pharmacy must hold a non-resident pharmacy permit issued by the Pennsylvania State Board of Pharmacy [14].

Does Pennsylvania Medicaid or Private Insurance Cover Armour Thyroid?

Pennsylvania Medicaid (Medical Assistance) covers Armour Thyroid for hypothyroidism with prior authorization. The Pennsylvania Department of Human Services Preferred Drug List places Armour Thyroid as a non-preferred agent, meaning levothyroxine must be tried first and must have failed before Medicaid will approve NDT [15]. Prior authorization documentation typically requires:

• A diagnosis code of hypothyroidism (ICD-10 E03.9 or specific subtypes)
• Evidence that the patient was on levothyroxine for at least 60 to 90 days
• Documentation of persistent symptoms or suboptimal lab values despite adequate levothyroxine dosing
• The prescriber's clinical rationale for NDT

The prior authorization process in Pennsylvania takes two to five business days for standard review. Expedited review is available if the prescriber documents medical urgency, typically completed within 72 hours [15].

Private insurers vary widely. Highmark, Independence Blue Cross, and UPMC Health Plan each have their own formulary tiers for thyroid medications. Armour Thyroid sits on Tier 2 or Tier 3 at most Pennsylvania commercial plans, meaning a copay of $30 to $75 per 30-day supply after the deductible. Your telehealth prescriber or their staff can run a real-time benefits check at the time of prescribing to confirm your out-of-pocket cost before the prescription is sent.

How Long Until You Receive Armour Thyroid After Starting the Process in Pennsylvania?

Timeline depends on your path to prescription. For a telehealth visit with labs already in hand, the fastest route runs:

• Day 0: Book and complete a telehealth visit.
• Day 1 to 2: Provider reviews labs and sends electronic prescription.
• Day 2 to 3: Retail pharmacy fills the prescription; same-day pickup at most CVS and Walgreens locations statewide.

If you need to order labs first, add five to seven days for a lab draw and results return. If your insurer requires prior authorization, add two to five business days. Shipping from a mail-order or compounding pharmacy adds two to four business days. The longest realistic timeline from first contact to first dose is approximately 14 days, which occurs when prior authorization, lab ordering, and mail-order compounding all occur sequentially.

Once you have your prescription, optimal dosing requires patience. NDT dose titration typically spans 8 to 12 weeks before a stable maintenance dose is established. The starting dose for most adults is 30 mg (0.5 grain) daily, increasing by 15 mg every two to four weeks based on labs and symptom response, up to a typical maintenance range of 60 to 120 mg daily [16]. TSH suppression below 0.5 mIU/L during titration may prompt a dose reduction to protect cardiac function [6].

Can You Transfer an Existing Armour Thyroid Prescription to Pennsylvania?

Yes. If you move to Pennsylvania or establish Pennsylvania residency while already taking Armour Thyroid, your prescription can be transferred to a Pennsylvania-licensed pharmacy. Pennsylvania pharmacy law allows one-time transfers of non-controlled prescriptions between pharmacies; because Armour Thyroid is not a controlled substance, the transfer is straightforward [17].

If you have remaining refills at an out-of-state pharmacy, contact that pharmacy and request a transfer to a Pennsylvania location or to a Pennsylvania-licensed mail-order pharmacy. Alternatively, your telehealth or in-person Pennsylvania prescriber can simply issue a new prescription. Because NDT is not a controlled substance under the Controlled Substances Act, there is no DEA-related restriction on issuing a new prescription across state lines or at a new Pennsylvania pharmacy [17].

Out-of-state prescribers who are not licensed in Pennsylvania cannot legally continue writing your prescriptions once you establish Pennsylvania residency. You will need a Pennsylvania-licensed prescriber, which again makes telehealth the fastest path if you have not yet established care in the state.

What Does the Research Say About Long-Term Safety of Armour Thyroid?

Long-term use of NDT at doses that keep TSH within the normal range appears to be safe in most patients. The primary documented risk of any thyroid hormone replacement, including NDT, is TSH suppression leading to bone loss and cardiac arrhythmia. A 2015 meta-analysis in the Journal of Bone and Mineral Research (N=1,256 women, 13 studies) found that subclinical hyperthyroidism defined as TSH <0.1 mIU/L was associated with a 2.16-fold increased risk of hip fracture [18]. A 2012 Cochrane systematic review of thyroid hormone replacement studies found no significant difference in safety outcomes between T4 monotherapy and combination T4/T3 regimens when TSH was kept in the normal range [19].

The FDA-approved prescribing information for Armour Thyroid warns against use in patients with uncorrected adrenal insufficiency, as thyroid hormone increases metabolic clearance of cortisol and can precipitate adrenal crisis [1]. Patients with adrenal fatigue symptoms should have a morning cortisol or ACTH stimulation test before starting NDT.

The 2019 American Thyroid Association task force on NDT, summarized by Idrees et al., noted that "combination therapy with T4 and T3 may be considered for patients who are dissatisfied with levothyroxine monotherapy despite adequate dosing and who have been counseled on the risks of therapy" [20]. This language represents a meaningful shift from prior ATA positions that discouraged NDT entirely.

Addressing Prior Authorization in Pennsylvania: A Step-by-Step Guide

For patients whose Pennsylvania insurer or Medicaid plan requires prior authorization (PA) for Armour Thyroid, the following steps make the process faster:

1. Ask your prescriber to submit the PA request at the same time as the prescription, not after the pharmacy rejects it at the counter.
2. Provide documentation of prior levothyroxine trials: the specific brand or generic, dose, duration, and reason for discontinuation or insufficiency.
3. Include lab values showing suboptimal Free T3 or elevated rT3 despite in-range TSH on levothyroxine. A Free T3 in the lower quartile of the reference range (below 3.0 pg/mL) strengthens the clinical rationale.
4. If the initial PA is denied, request a peer-to-peer review. Your prescriber speaks directly with the insurance medical director. Approval rates after peer-to-peer review in thyroid hormone cases are meaningfully higher than after initial denial.
5. If the peer-to-peer fails, file an appeal citing the Hoang et al. 2013 crossover trial data [3] and the 2019 ATA task force statement [20] as supporting literature for individualized therapy.

Pennsylvania also has an external review process under the Pennsylvania Insurance Department for commercial insurance denials. Patients whose PA denial is upheld internally have the right to request an independent review organization (IRO) review within 15 days of the final adverse determination [21].

Armour Thyroid Dosing Basics for New Patients in Pennsylvania

Getting the prescription is only step one. Knowing what to expect from the medication helps patients stay on track. Armour Thyroid is taken orally once daily, on an empty stomach, at least 30 to 60 minutes before breakfast or any calcium- or iron-containing food. Calcium, iron, antacids, and certain cholesterol medications (particularly cholestyramine) reduce NDT absorption by binding T4 and T3 in the gut [1].

Common tablets available in the US through Allergan include 15 mg (0.25 grain), 30 mg (0.5 grain), 60 mg (1 grain), 90 mg (1.5 grain), 120 mg (2 grain), 180 mg (3 grain), 240 mg (4 grain), and 300 mg (5 grain). Pennsylvania retail pharmacies stock the most common strengths (30 mg, 60 mg, 90 mg, 120 mg) reliably; the 15 mg and 240 mg strengths may require special ordering [1].

Patients switching from levothyroxine to Armour Thyroid use a conversion ratio of approximately 100 mcg levothyroxine = 60 mg (1 grain) Armour Thyroid, though individual response varies and the conversion is not perfectly linear due to the added T3 content [16]. A patient on 100 mcg levothyroxine would typically start at 60 mg Armour Thyroid and have labs rechecked at six weeks. TSH should be assessed using a third-generation TSH assay with a functional sensitivity of 0.02 mIU/L or better, as recommended by the American Thyroid Association [6].